SMARTOMICS

Welcome to the Brand page for “SMARTOMICS”, which is offered here for Gene therapy and prophylaxis products, gene delivery products; enzymes and enzyme preparations for use in the medical industry, vectors, retroviral vectors, vector and retroviral vector manufacturing preparations, all for use in gene delivery technology, products for use in vector production technologies, neurogenomics products; pharmaceutical preparations containing nucleic acids for assistance in delivering gene therapy and prophylaxis, gene delivery systems; vaccines for use in the treatment of diseases of the brain and nervous system and motor neurone diseases, gene therapy and prophylaxis and chemicals and biochemicals for use in the medical industry;chemical and biochemical products for use in the gene delivery technology, enzymes and chemicals for in vitro use in laboratories and for analysis for use in the gene delivery technology, micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid and variations thereof, all for in vivo use in gene delivery technology and catalysts for gene delivery technology;scientific and medical research and development, genetic engineering services, biotechnology services, biotechnology research in the development of therapeutic products and vaccines; medical research and development in the field of vector production technologies;.

Its status is currently believed to be active. Its class is unavailable. “SMARTOMICS” is believed to be currently owned by “Oxford BioMedica plc”.